A new class of bronchodilator improves lung function in COPD: a trial with GSK961081

GSK961081 is a bifunctional molecule demonstrating both muscarinic antagonist and β-agonist activities. This was a 4-week, multicentre, randomised, double-blind, double-dummy, placebo and salmeterol controlled parallel group study. Doses ranging across three twice-daily doses and three once-daily do...

Descripción completa

Detalles Bibliográficos
Autores principales: Wielders, Pascal L.M.L., Ludwig-Sengpiel, Andrea, Locantore, Nicholas, Baggen, Suus, Chan, Robert, Riley, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787816/
https://www.ncbi.nlm.nih.gov/pubmed/23429913
http://dx.doi.org/10.1183/09031936.00165712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787816/
https://www.ncbi.nlm.nih.gov/pubmed/23429913
http://dx.doi.org/10.1183/09031936.00165712

Ejemplares similares